1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Defined culture conditions robustly maintain human stem cell pluripotency, highlighting a role for Ca2+ signaling
- Contribution to journal › Article
- 2024
-
Mark
Unraveling the brain's response to COVID-19 : How SARS-CoV-2 afflicts dopaminergic neurons
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury
- Contribution to journal › Article
- 2023
-
Mark
Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders
- Contribution to journal › Scientific review
